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BACKGROUND: This study was performed to determine whether genetic polymorphisms of aryl hydrocarbon recep-
tor repressor (AhRR), glutathione-S-transferase M1 (GSTM1) and glutathione-S-transferase T1 (GSTT1) are associ-
ated with susceptibility to advanced stage endometriosis in a Korean population. METHODS: This study comprised
316 women with advanced stage endometriosis and 256 control women without endometriosis. Genotyping of the
AhRR codon 185 was performed by real-time polymerase chain reaction (PCR) analysis. GSTM1 and GSTT1 geno-
typing for gene deletions were carried out by multiplex PCR analysis. RESULTS: G allele frequency at codon 185
of AhRR was increased in patients with endometriosis (P5 0.047), and there was a trend for an association of C/
G 1 G/G genotypes with risk of endometriosis (P 5 0.06). The proportion of null mutation at GSTT1 also tended
to increase (P5 0.06) in patients with endometriosis, whereas there was no difference in the genotype distribution
of GSTM1 genes. Analyzing AhRR and GSTT1 together, we found that patients with high-risk genotypes at both
loci have increased risk of endometriosis, compared with patients without high-risk genotypes (P 5 0.015). CON-
CLUSIONS: These findings suggest that the AhRR codon 185 and GSTT1 polymorphisms are associated with the
risk of advanced stage endometriosis.
Keywords: aryl hydrocarbon receptor repressor; glutathione-S-transferase M1; glutathione-S-transferase T1; endometriosis;
polymorphism
Introduction
Endometriosis is defined as the presence of endometrial tissue
outside the uterus, causing diverse diseases, including inferti-
lity, pelvic pain and dysmenorrhea. The prevalence of endo-
metriosis has been found to range from 2 to 18% among
women who seek tubal ligations and from 5 to 50% within
infertile women (Missmer and Cramer, 2003). Although retro-
grade menstruation is widely accepted as a major contributing
factor in the pathogenesis of endometriosis, it is also a common
phenomenon occurring in up to 90% of menstruating women
with patent fallopian tubes (Halme et al., 1984). Therefore, it
has yet to be determined why endometriosis affects only a
certain group of women.
Endometriosis shows heritable tendencies, with 5–8-folds
increased risks for first-degree relatives, indicating that
polygenic and multifactorial etiology is far more likely to be
the cause than Mendelian inheritance (Simpson and Bischoff,
2002). There is also growing evidence that exposure to
environmental contaminants could contribute to the patho-
genesis of endometriosis. Dioxin is a typical environmental
contaminant exerting adverse estrogen-related effects (Bock,
1994), and has been shown to induce a dose-dependent increase
in severity of endometriosis in non-human primates (Rier et al.,
1993). Extrapolation to women was initially thought to be epi-
demiologically plausible, as Belgium, with the highest dioxin
pollution in the world, has the highest incidence of endometrio-
sis as well as the highest prevalence of severe endometriosis
(Giudice and Kao, 2004). However, Guo et al. (2004)
pointed out that the statistical analysis in the Rier et al.
(1993) report was not sound, and there has been no human
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epidemiological study definitely linking dioxin to the risk of
endometriosis.
Based upon the possible contribution of dioxin to the patho-
genesis of endometriosis along with its genetic predisposition,
it has been postulated that variants in the genes involved in
xenobiotic detoxification process may be associated with the
risk of endometriosis. Indeed, several investigators have
reported possible involvement of some detoxification enzyme
gene polymorphisms in the development of endometriosis
(Baranova et al., 1997, 1999; Arvanitis et al., 2003; Lin
et al., 2003; Hsieh et al., 2004). However, a meta-analysis
(Guo, 2005) and a systematic review (Guo, 2006) do not
support their findings and suggest that there is no strong indi-
cation that any specific detoxification enzyme gene polymorph-
ism is consistently associated with susceptibility to
endometriosis. Recently, Tsuchiya et al. (2005) revealed that
a genetic polymorphism of aryl hydrocarbon receptor repressor
(AhRR), a down-regulator of the genes regulated by AhR, is
associated with susceptibility to endometriosis in a Japanese
population. They have shown that the C/G and the G/G geno-
types at codon 185 of AhRR are associated with the risk of
endometriosis. However, it is necessary to clarify whether
AhRR polymorphism is associated with endometriosis in
another ethnic group with adequate sample number, since
their report included only a small number of patients and incon-
sistent results have been reported in the same population
(Watanabe et al., 2001).
The primary goal of the present study was to explore the
association between AhRR polymorphism and the risk of
advanced endometriosis in a Korean population. We also
tried to determine whether the genetic polymorphisms of
glutathione-S-transferase M1 (GSTM1) and glutathione-
S-transferase T1 (GSTT1) are associated with susceptibility to
endometriosis in the same population.
Materials and Methods
Subjects
Peripheral blood was obtained from the patients who had undergone
diagnostic laparoscopy, pelviscopic surgery, exploratory laparotomy
or transabdominal hysterectomy from October 2000 to September
2005. All subjects were of Korean origin, which is made up of a
single ethnic group. A total of 316 patients had surgical and histologi-
cal evidence of advanced endometriosis, whereas 256 patients without
the disease served as controls. All patients in the endometriosis group
had ovarian endometrioma, and the extent of the disease was staged
according to the guidelines of the American Society for Reproductive
Medicine (1997). Sixty-four patients were diagnosed as having stage
III and 252 patients had stage IV endometriosis. None of the subjects
had lived in the vicinity of any potentially higher risk environments,
such as chemical factories or farms, had specific dietary habits, such
as vegetarianism or nearly pure meat or fish diets, or had received
hormone therapy during the previous 12 months.
All of the patients who had the diagnosis of minimal or mild endo-
metriosis were excluded in both the case and control groups. The indi-
cations for surgery or the diagnostic laparoscopy among the
endometriosis group were dysmenorrhea (n ¼ 95), pelvic pain (n ¼
74), infertility (n ¼ 74), adnexal mass (n ¼ 63) and others (n ¼ 10).
Patients with leiomyoma, adenomyosis, invasive carcinoma of the
uterine cervix or ovarian cancer were excluded from the control
group. The indications for surgery or the diagnostic laparoscopy
among the control group were benign ovarian cyst (n ¼ 155), pelvic
pain or dysmenorrhea (n ¼ 24), tubal ligation (n ¼ 23), carcinoma
in situ of the uterine cervix (n ¼ 20), tubal reanastomosis (n ¼ 12)
and others (n ¼ 22). The review board for human research of Seoul
National University Hospital approved this project, and informed
written consent was obtained from each woman. Underlying infertility
rates were 1.6% in the control group and 23.4% in the endometriosis
group. Ages ranged from 19 to 40 years (29.6+4.3, mean+SD) in
the endometriosis group and from 16 to 55 years (36.9+ 9.2) in the
control group.
Genomic DNA analysis
Peripheral blood was drawn from each patient and collected in an
EDTA-containing tube, and genomic DNA was extracted with the
Wizard DNA Purification Kit (Promega, Madison, WI, USA). The
AhRR polymorphism was genotyped by real-time PCR analysis on
an ABI Prism 7000 Sequence Detection System (Applied Biosystems,
Foster City, CA, USA) using fluorescent labeled probes. Each 20 ml
PCR reaction contained 10 pmol of forward primer 50-AGACGG
ATGTTATGCACCAGAA-30, 10 pmol of reverse primer 50-AG
AGGCAGCGATGTGTTATGG-30, 4 pmol of C-allele probe
50-(FAM)-TGGGCAGCCCCCCGCC-(TAMRA)-30, 4 pmol of G
-allele probe 50-(VIC)-TGGGCAGGCCCCGCC-(TAMRA)-30, 10 ml
of 2X TaqMan Universal PCR Master Mix (Applied Biosystems)
and 25 ng DNA. The PCR cycling conditions consisted of one 2 min
cycle at 508C and one 10 min cycle at 958C, followed by 40 cycles
of 958C for 15 s and 608C for 1 min. Distilled water was used as a
negative PCR control in each amplification.
GSTM1 and GSTT1 genotyping for gene deletions were carried out
by multiplex PCR analysis. The PCR primers for the GSTM1 and the
GSTT1 polymorphisms were 50-GAACTCCCTGAAAAGCTAAAGC
-30 (forward) and 50-GTTGGGCTCAAATATACGGTGG-30 (reverse)
(Bioneer, Seoul, Korea), which produced a 219 bp product, and
50-TTCCTTACTGGTCCTCACATCTC-30 (forward) and 50-TCACC
GGATCATGGCCAGCA-30 (reverse) (Bioneer), which produced a
459 bp product, respectively. Amplification of b-globulin gene with
the primers 50-CAACTTCATCCACGTTCACC-30 and 50-GAA
GAGCCA AGGACAGGTAC-30 (Bioneer) was used as an internal
control and produced a 268 bp product. A 25 ng sample of genomic
DNA was added to a PCR mixture containing 1.5 mM MgCl2,
0.2 mM dNTPs, 0.4 mM each primer and 1.0 U of Taq polymerase.
The PCR cycling conditions were as follows: an initial denaturation
step at 948C for 5 min, amplification for 40 cycles at 948C for
1 min, 658C for 1 min and 728C for 1 min, followed by a final exten-
sion step at 728C for 5 min. The amplified product was visualized in an
ethidium bromide stained 3% agarose gel. If the study subject is null
for the gene, no PCR product is present, and the b-globulin gene frag-
ment acts as a positive PCR control (Fig. 1).
Statistical analysis
Power calculation based on the numbers of patients and controls in the
present study revealed that the power to detect a significant difference
of genotype frequency similar to the report by Tsuchiya et al. (2005)
(25.3% versus 45.8% for CC genotype) was 1.0. Genotype distri-
butions were examined for significant departure from Hardy–
Weinberg equilibrium by a goodness of fit chi-square test. Chi-square
analysis and univariate logistic regression were used to evaluate
differences in the proportions of the genotypes between the endome-
triosis and control groups. Distribution of two genotypes at two
loci was analyzed by univariate logistic regression. P, 0.05 was
considered significant.
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Results
Genotyping of the three polymorphic loci was successfully
achieved for all subjects. Genotypic distributions of the codon
185 of AhRR genes were in Hardy–Weinberg equilibrium in
both groups. G allele frequency at codon 185 of AhRR genes
was increased in patients with endometriosis [38% versus
32.2%, P¼ 0.047, odds ratio (OR): 1.29, 95% confidence interval
(CI): 1.01–1.65] (Table 1). There was a trend for patients with C/
G þ G/G genotypes to have an increased risk of endometriosis
compared with those with C/C genotypes (61.4% versus
53.5%, P¼ 0.058, OR: 1.38, 95% CI: 0.99–1.33) (Table 1).
The proportion of null mutation at GSTT1 also tended to
increase in patients with endometriosis (56.3% versus 48.4%,
P ¼ 0.060, OR: 1.37, 95% CI: 0.99–1.91), whereas there
was no difference in the genotype distribution of GSTM1
genes (57.9% versus 57.0%, P ¼ 0.865, OR: 0.97, 95% CI:
0.69–1.35) (Table 2). Analyzing AhRR and GSTT1 together,
we found that patients with high-risk genotypes at both loci
have increased risk of endometriosis, compared with patients
without any high-risk genotypes (P ¼ 0.015, OR: 1.86, 95%
CI: 1.13–3.06) (Table 3).
Discussion
Despite its physiological role in the detoxification of polycyclic
aromatic compounds, the activity of cytochrome P450 1A1
(CYP1A1) enzyme can be deleterious, since it generates muta-
genic metabolites and active oxygen (Nebert and Gonzalez,
1987; Nebert et al., 2000). The induction of CYP1A1 gene is
regulated by AhR that is present in the cytosol in a complex
with heat shock protein (Hsp) 90 in the absence of ligand
(Mimura and Fujii-Kuriyama, 2003). Upon binding to
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the AhR
complex translocates into the nucleus and the AhR dissociates
from Hsp90 complex to form a heterodimer with its partner
molecule, AhR nuclear translocator (ARNT). The AhR/ARNT
heterodimer recognizes a DNA enhancer element sequence,
designated xenobiotic responsive element (XRE), located in
the promoter region of CYP1A1 gene, resulting in the enhanced
expression of the gene (Mimura and Fujii-Kuriyama, 2003).
Mimura et al. (1999) have identified AhRR and demonstrated
that AhRR localizes in the nuclei and forms a heterodimer
with Arnt constitutively. They have shown that the AhRR/
ARNT heterodimer also recognizes the XRE, but functions as a
transcriptional repressor, indicating that AhRR functions as a
negative regulator of AhR by competing with AhR for forming
a heterodimer with Arnt and binding to the XRE sequence.
Extensive studies on the AhR function using AhR-deficient
mice have shown that AhR is responsible for most of toxic
effects caused by TCDD, with induction of CYP1A1 gene
and other dioxin-inducible genes (Mimura et al., 1997;
Shimizu et al., 2000). Accordingly, loss or reduction of
AhRR expression in cells can lead to increased susceptibility
to toxic effects of TCDD by impeding the negative regulatory
effects of AhRR. Based on the expectation that polymorphisms
of AhRR genes could be relevant to the individual’s suscepti-
bility to dioxins, some investigators have explored the possible
association of these polymorphisms with susceptibility to
specific diseases for which environmental contaminants could
contribute to the pathogenesis. Evaluating the genotype fre-
quency of the AhRR codon 185 polymorphism in a Japanese
population, Fujita et al. (2002) revealed that there is a signifi-
cant difference between subjects with and without micropenis,
suggesting that subjects with a specific genotype of the AhRR
codon 185 polymorphism might have increased susceptibility
to the undermasculinizing effects of dioxin exposure in utero,
Figure 1: Patterns of multiplex PCR for glutathione-S-transferase M1
(GSTM1) and glutathione-S-transferase T1 (GSTT1) genes b-Globulin
gene was used as an internal positive control. Lane 1 and Lane 7 are
the 100 bp DNA ladder and Lane 6 is negative control. Lane 2 repre-
sents null genotypes for both GSTM1 and GSTT1 genes. Lane 3 is
the wild genotype for the GSTM1 gene and the null genotype for the
GSTT1 gene, lane 4 is the null genotype for the GSTM1 and the
wild genotype for the GSTT1 gene and lane 5 represents wild geno-
types for both GSTM1 and GSTT1 genes.
Table 1: Distribution of codon 185 polymorphism in the AhRR gene in endometriosis patients (n ¼ 316) and controls (n ¼ 256)
Genotype/
allele
Endometriosis
n (%)
Control
n (%)
P-value OR (95% CI)
CC 122 (38.6) 119 (46.5) Reference
CG 148 (46.8) 109 (42.6) 0.12a 1.32a (0.93–1.89)
GG 46 (14.6) 28 (10.9) 0.08a 1.60a (0.94–2.73)
CC 122 (38.6) 119 (46.5) 0.058b 1.38b (0.99–1.33)
Non-CC 194 (61.4) 137 (53.5)
C allele 392 (62) 347 (67.8) 0.047b
G allele 240 (38) 165 (32.2) 0.047b 1.29 (1.01–1.65)
aEvaluated by logistic regression analysis in comparison with the control group.
bEvaluated by chi-square test in comparison with the control group.
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presumably through the diminished inhibition of AHR-
mediated signaling. These findings are consistent with genetic
studies performed in other Japanese populations (Watanabe
et al., 2004; Soneda et al., 2005).
Recently, Tsuchiya et al. (2005) have shown that the C/G
and the G/G genotypes at codon 185 of AhRR are associated
with the risk of endometriosis in a Japanese population.
However, they suggested that their findings may have limita-
tions due to the small number of subjects recruited, and that
further studies are necessary in other ethnic groups with
larger sample size. Recruiting a total of 572 patients who had
been confirmed surgically, the present study demonstrated
that G allele frequency at codon 185 of AhRR was increased
in patients with endometriosis (P ¼ 0.047), but the C/G þ
G/G genotypes showed only a trend toward association with
the risk of endometriosis. Since the proportion of null mutation
atGSTT1 also showed this trend in patients with endometriosis,
we analyzed the risk of the disease according to the number of
putative high-risk genotype at the two loci. Compared with
patients without any high-risk genotypes, those with two high-
risk genotype(s) at the two loci had significantly increased risk
of endometriosis.
Based on the findings of the present study, it may be specu-
lated that a single genetic polymorphism involving AhRR or
GSTT1 exhibits only a marginal effect, but can confer a signifi-
cant increase in the risk of endometriosis if the putative high-
risk genotypes at the two loci are combined. Performing a
meta-analysis, Guo (2005) has shown that there is no evidence
that women with GSTM1 null genotype have increased risk of
endometriosis, but reported that the risk associated withGSTT1
null genotype is higher than other genotypes, although the
estimate could easily loose its significance, if there is a realistic
69–80% publication probability. Guo suggested that it is poss-
ible that GSTM1 or GSTT1 alone does not exhibit an appreci-
able effect on the risk of endometriosis but interacts with
other genes to confer, jointly, increased risk of endometriosis.
Indeed, testing for association of endometriosis with GSTM1,
GSTT1 and CYP1A1 MspI polymorphisms, Hadfield et al.
(2001) have shown that the combination of the GSTM1 null
genotype and the CYP1A1 MspI polymorphism was associated
with increased risk of endometriosis, whereas no significant
differences were found between cases and controls in the fre-
quencies of the GSTM1,GSTT1 and CYP1A1 MspI polymorph-
isms. It might be suggested that any single genetic
polymorphism in the aryl hydrocarbon gene battery does not
lead to a serious increase in the risk of developing endometrio-
sis due to the possible genetic redundancy existing in the detox-
ification pathways. However, if an individual has high-risk
genotypes at multiple loci that are involved in the detoxifica-
tion pathways, it is possible that she could have significantly
increased risk of endometriosis.
The mean age of the control subjects in the present study was
higher than the endometriosis patients. However, as described
by Hadfield et al. (2001), recruiting women from this age group
has a merit of maximizing the probability that they were unaf-
fected by endometriosis, i.e. to avoid including younger
women who might develop the disease in later life. The
control group in the present study may not be representative
of the general population, since they all had undergone diag-
nostic laparoscopy, pelviscopic surgery, exploratory laparot-
omy or transabdominal hysterectomy. However, our study
had the advantage of using a completely disease-free control
Table 2: Prevalence of homozygosity for the GSTM1 and GSTT1 null mutations in endometriosis patients and controls
Group GSTM1 GSTT1
Present
n (%)
Null
n (%)
P-value OR (95% CI) Present
n (%)
Null
n (%)
P-value OR (95% CI)
Endometriosis (n ¼ 316) 133 (42.1) 183 (57.9) 0.865a 0.97a (0.6921.35) 138 (43.7) 178 (56.3) 0.060a 1.37a (0.99–1.91)
Control (n ¼ 256) 110 (43.0) 146 (57.0) 132 (51.6) 124 (48.4)
aEvaluated by chi-square test in comparison with the control group.
Table 3: Risk of advanced stage endometriosis according to the number of possible high risk AhRR and GSTT1 genotypes
Number
of high
risk
genotypes
Genotypes group P-value and OR
AhRR GSTT1 Endometriosis
n (%)
Control
n (%)
Crude
P-value
Crude OR (95%
CI)
Age-adjusted
P-value
Age-adjusted
OR (95% CI)
0 CC Present 54 (17.1) 52 (20.3)
1 CC
CG
or
GG
Null
Present
152 (48.1) 147 (57.4) 0.985a 1.00 (0.64–1.55) 0.594a 0.87 (0.53–1.45)
2 CG
or
GG
Null 110 (34.8) 57 (22.3) 0.015a 1.86 (1.13–3.06) 0.048a 1.77 (1.01–3.13)
aVersus zero high risk genotypes.
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group, and thus compared the genotypes between individuals
with and without advanced endometriosis more completely.
In summary, the present study has shown that a single genetic
polymorphism involving AhRR or GSTT1 exhibits a marginal
effect, but can confer a significant increase in the risk of
endometriosis if the putative high-risk genotypes at the two
loci are combined. Our data suggest that combined analysis of
genetic polymorphisms in the several candidate genes involved
in xenobiotic detoxification process is necessary to elucidate the
possible genetic etiologic factors in endometriosis.
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